| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aluminum — a ubiquitous, non-essential trivalent metal (Al³⁺ in biological contexts) and environmental exposure agent that has been investigated as a potential contributing factor to Alzheimer’s disease (AD) via neurotoxic, pro-aggregant, and pro-inflammatory mechanisms. It is best classified as an environmental metal toxicant/exposure (not a therapeutic). Common abbreviations include Al and Al³⁺. Primary exposure sources include diet, certain pharmaceuticals (notably some antacids), occupational settings, and drinking-water treatment residues (aluminum-based coagulants); susceptibility to tissue accumulation is most relevant in renal impairment and high/atypical exposure contexts. Primary mechanisms (ranked):
Bioavailability / PK relevance: Oral absorption of aluminum is generally low, but increases with certain ligands (e.g., citrate) and in specific physiological states; distribution into brain is limited yet biologically plausible over long timescales in susceptible contexts. Elimination is predominantly renal; impaired kidney function markedly increases retention and risk of neurotoxicity. From a public-health standpoint, drinking-water guidance often emphasizes practicable treatment targets (commonly ~0.1–0.2 mg/L) rather than a strict health-based limit, reflecting treatment optimization constraints. In-vitro vs systemic exposure relevance: Many mechanistic in-vitro studies use aluminum concentrations that may exceed typical systemic levels from everyday exposure; interpretation is therefore highly dose- and speciation-dependent. Chronic, low-level exposure hypotheses rely more on long-duration accumulation/interaction models than on acute high-concentration effects. Clinical evidence status: Mixed and controversial. Epidemiology on aluminum in drinking water and AD risk is inconsistent across studies and geographies; overall evidence is insufficient to establish causality. A historical small clinical study of desferrioxamine (a trivalent metal chelator) reported slowed functional decline, but this has not been definitively replicated and does not prove aluminum causation. Aluminum and Alzheimer’s disease (AD) has been investigated for decades, but it remains controversial-Elevated aluminum levels have been found in the brain tissue of some individuals with AD. -Animal studies have shown that aluminum exposure can: -Promote beta-amyloid aggregation (a hallmark of AD) -Induce oxidative stress -Disrupt mitochondrial function -In vitro studies suggest aluminum may promote tau phosphorylation and neuroinflammation—also key in AD pathology. -Some epidemiological studies (e.g., France, UK, Canada) found higher AD rates in areas with aluminum-contaminated water (>100 µg/L). -bioavailability of aluminum may increase with age, increasing aluminum. Negative Findings: -Typical dietary aluminum intake (via food, water, cookware) is considered safe by most regulatory agencies. -Large-scale population studies generally don’t show a strong aluminum–AD link Sources: Cookware (e.g., foil, pots) Minimal if anodized or non-reactiveSurface waters (lakes or rivers) are often treated with aluminum sulphate to induce floculation and remove organic and other contaminants. (0.023 surface water vs 0.006 mg/l underground water) -many authors have postulated that aluminum in drinking water may be more bioavailable than aluminum from other sources. -it is plausible that there is an increase in aluminum absorption with age Aluminum and Alzheimer’s disease mechanistic axes
TSF legend: P: 0–30 min R: 30 min–3 hr G: >3 hr |
| 4124- | Alum, | The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders |
| - | Review, | AD, | NA |
| 4130- | Alum, | Silica and aluminum in drinking water and cognitive impairment in the elderly |
| - | Study, | AD, | NA |
| 4132- | Alum, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
| - | Study, | AD, | NA |
| 4135- | Alum, | Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer's Disease |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:363 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid